annual cash & cash equivalents:
$553.35M-$204.22M(-26.96%)Summary
- As of today (May 20, 2025), TER annual cash & cash equivalents is $553.35 million, with the most recent change of -$204.22 million (-26.96%) on December 31, 2024.
- During the last 3 years, TER annual cash & cash equivalents has fallen by -$568.85 million (-50.69%).
- TER annual cash & cash equivalents is now -50.69% below its all-time high of $1.12 billion, reached on December 31, 2021.
Performance
TER Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$475.63M-$77.72M(-14.05%)Summary
- As of today (May 20, 2025), TER quarterly cash & cash equivalents is $475.63 million, with the most recent change of -$77.72 million (-14.05%) on March 30, 2025.
- Over the past year, TER quarterly cash & cash equivalents has dropped by -$231.77 million (-32.76%).
- TER quarterly cash & cash equivalents is now -57.62% below its all-time high of $1.12 billion, reached on December 31, 2021.
Performance
TER quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TER Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.0% | -32.8% |
| 3 y3 years | -50.7% | -40.1% |
| 5 y5 years | -28.5% | -19.9% |
TER Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.7% | at low | -44.4% | +12.7% |
| 5 y | 5-year | -50.7% | at low | -57.6% | +12.7% |
| alltime | all time | -50.7% | >+9999.0% | -57.6% | >+9999.0% |
TER Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $475.63M(-14.0%) |
| Dec 2024 | $553.35M(-27.0%) | $553.35M(+8.5%) |
| Sep 2024 | - | $510.04M(+20.9%) |
| Jun 2024 | - | $421.90M(-40.4%) |
| Mar 2024 | - | $707.40M(-6.6%) |
| Dec 2023 | $757.57M(-11.4%) | $757.57M(+18.9%) |
| Sep 2023 | - | $636.96M(+3.9%) |
| Jun 2023 | - | $613.21M(-5.5%) |
| Mar 2023 | - | $649.21M(-24.0%) |
| Dec 2022 | $854.77M(-23.8%) | $854.77M(+20.3%) |
| Sep 2022 | - | $710.75M(+24.3%) |
| Jun 2022 | - | $572.02M(-28.0%) |
| Mar 2022 | - | $794.60M(-29.2%) |
| Dec 2021 | $1.12B(+22.8%) | $1.12B(+4.0%) |
| Sep 2021 | - | $1.08B(+13.1%) |
| Jun 2021 | - | $954.44M(+14.8%) |
| Mar 2021 | - | $831.15M(-9.1%) |
| Dec 2020 | $914.12M(+18.1%) | $914.12M(-3.3%) |
| Sep 2020 | - | $945.18M(+30.3%) |
| Jun 2020 | - | $725.43M(+22.2%) |
| Mar 2020 | - | $593.49M(-23.3%) |
| Dec 2019 | $773.92M(-16.5%) | $773.92M(+30.3%) |
| Sep 2019 | - | $593.94M(+20.0%) |
| Jun 2019 | - | $495.11M(+2.4%) |
| Mar 2019 | - | $483.73M(-47.8%) |
| Dec 2018 | $926.75M(+115.6%) | $926.75M(+13.8%) |
| Sep 2018 | - | $814.02M(+69.5%) |
| Jun 2018 | - | $480.38M(-24.7%) |
| Mar 2018 | - | $637.87M(+48.4%) |
| Dec 2017 | $429.84M(+39.6%) | $429.84M(+2.7%) |
| Sep 2017 | - | $418.68M(-30.0%) |
| Jun 2017 | - | $598.35M(+84.3%) |
| Mar 2017 | - | $324.75M(+5.5%) |
| Dec 2016 | $307.88M(+16.3%) | $307.88M(+3.3%) |
| Sep 2016 | - | $297.94M(-21.8%) |
| Jun 2016 | - | $381.10M(+19.3%) |
| Mar 2016 | - | $319.36M(+20.6%) |
| Dec 2015 | $264.70M(-10.0%) | $264.70M(-10.0%) |
| Sep 2015 | - | $294.22M(-2.2%) |
| Jun 2015 | - | $300.69M(+37.3%) |
| Mar 2015 | - | $218.94M(-25.6%) |
| Dec 2014 | $294.26M(-13.9%) | $294.26M(+39.0%) |
| Sep 2014 | - | $211.70M(-16.9%) |
| Jun 2014 | - | $254.63M(+9.5%) |
| Mar 2014 | - | $232.63M(-31.9%) |
| Dec 2013 | $341.64M(+0.8%) | $341.64M(-40.4%) |
| Sep 2013 | - | $572.87M(+151.7%) |
| Jun 2013 | - | $227.60M(-25.4%) |
| Mar 2013 | - | $305.22M(-9.9%) |
| Dec 2012 | $338.92M(-40.9%) | $338.92M(-30.2%) |
| Sep 2012 | - | $485.69M(-17.5%) |
| Jun 2012 | - | $589.06M(+10.4%) |
| Mar 2012 | - | $533.40M(-7.0%) |
| Dec 2011 | $573.74M(+44.3%) | $573.74M(-47.6%) |
| Sep 2011 | - | $1.10B(+140.5%) |
| Jun 2011 | - | $455.40M(+8.4%) |
| Mar 2011 | - | $420.27M(+5.7%) |
| Dec 2010 | $397.74M(-4.6%) | $397.74M(-8.3%) |
| Sep 2010 | - | $433.92M(+7.4%) |
| Jun 2010 | - | $404.00M(+18.1%) |
| Mar 2010 | - | $342.01M(-17.9%) |
| Dec 2009 | $416.74M(+29.1%) | $416.74M(+2.5%) |
| Sep 2009 | - | $406.74M(+21.7%) |
| Jun 2009 | - | $334.08M(+19.7%) |
| Mar 2009 | - | $279.06M(-13.5%) |
| Dec 2008 | $322.70M(-42.6%) | $322.70M(+10.3%) |
| Sep 2008 | - | $292.57M(+2.3%) |
| Jun 2008 | - | $286.09M(-11.4%) |
| Mar 2008 | - | $323.08M(-42.6%) |
| Dec 2007 | $562.37M(-1.0%) | $562.37M(+31.1%) |
| Sep 2007 | - | $429.08M(+9.1%) |
| Jun 2007 | - | $393.21M(-3.1%) |
| Mar 2007 | - | $405.59M(-28.6%) |
| Dec 2006 | $568.02M | $568.02M(-24.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $755.03M(+124.4%) |
| Jun 2006 | - | $336.52M(+4.3%) |
| Mar 2006 | - | $322.78M(-5.3%) |
| Dec 2005 | $340.70M(+62.9%) | $340.70M(+47.9%) |
| Sep 2005 | - | $230.34M(+15.7%) |
| Jun 2005 | - | $199.06M(+4.8%) |
| Mar 2005 | - | $190.01M(-9.1%) |
| Dec 2004 | $209.15M(-8.4%) | $209.15M(-20.8%) |
| Sep 2004 | - | $264.02M(+17.7%) |
| Jun 2004 | - | $224.34M(+0.6%) |
| Mar 2004 | - | $222.97M(-2.4%) |
| Dec 2003 | $228.44M(-9.2%) | $228.44M(+22.2%) |
| Sep 2003 | - | $187.00M(-21.4%) |
| Jun 2003 | - | $237.90M(+8.2%) |
| Mar 2003 | - | $219.88M(-12.6%) |
| Dec 2002 | $251.52M(-20.8%) | $251.52M(-13.1%) |
| Sep 2002 | - | $289.36M(-7.3%) |
| Jun 2002 | - | $312.29M(+47.8%) |
| Mar 2002 | - | $211.35M(-33.5%) |
| Dec 2001 | $317.59M(+31.0%) | $317.59M(+181.7%) |
| Sep 2001 | - | $112.76M(-21.7%) |
| Jun 2001 | - | $144.04M(-16.0%) |
| Mar 2001 | - | $171.46M(-29.3%) |
| Dec 2000 | $242.42M(+33.7%) | $242.42M(+6.8%) |
| Sep 2000 | - | $227.09M(+39.1%) |
| Jun 2000 | - | $163.25M(+25.4%) |
| Mar 2000 | - | $130.19M(-28.2%) |
| Dec 1999 | $181.30M(-2.3%) | $181.30M(+49.6%) |
| Sep 1999 | - | $121.20M(-15.4%) |
| Jun 1999 | - | $143.28M(-26.8%) |
| Mar 1999 | - | $195.76M(+5.5%) |
| Dec 1998 | $185.50M(+148.3%) | $185.50M(+41.3%) |
| Sep 1998 | - | $131.26M(+95.0%) |
| Jun 1998 | - | $67.31M(+104.5%) |
| Mar 1998 | - | $32.91M(-55.9%) |
| Dec 1997 | $74.70M(-62.9%) | $74.70M(-13.1%) |
| Sep 1997 | - | $85.98M(+85.0%) |
| Jun 1997 | - | $46.48M(-49.3%) |
| Mar 1997 | - | $91.69M(-54.5%) |
| Dec 1996 | $201.45M(+10.6%) | $201.45M(-30.9%) |
| Sep 1996 | - | $291.56M(+42.7%) |
| Jun 1996 | - | $204.35M(+19.1%) |
| Mar 1996 | - | $171.59M(-5.8%) |
| Dec 1995 | $182.16M(-0.4%) | $182.16M(-22.2%) |
| Sep 1995 | - | $234.19M(+60.9%) |
| Jun 1995 | - | $145.52M(-1.4%) |
| Mar 1995 | - | $147.52M(-19.3%) |
| Dec 1994 | $182.81M(+27.3%) | $182.81M(+26.5%) |
| Sep 1994 | - | $144.54M(-3.9%) |
| Jun 1994 | - | $150.35M(+17.5%) |
| Mar 1994 | - | $127.97M(-10.9%) |
| Dec 1993 | $143.60M(+113.1%) | $143.60M(+6.4%) |
| Sep 1993 | - | $135.00M(+16.4%) |
| Jun 1993 | - | $116.00M(+22.2%) |
| Mar 1993 | - | $94.90M(+40.8%) |
| Dec 1992 | $67.40M(+90.4%) | $67.40M(+6.8%) |
| Sep 1992 | - | $63.10M(+21.1%) |
| Jun 1992 | - | $52.10M(+44.7%) |
| Mar 1992 | - | $36.00M(+1.7%) |
| Dec 1991 | $35.40M(+378.4%) | $35.40M(+58.7%) |
| Sep 1991 | - | $22.30M(+537.1%) |
| Jun 1991 | - | $3.50M(-22.2%) |
| Mar 1991 | - | $4.50M(-39.2%) |
| Dec 1990 | $7.40M(+89.7%) | $7.40M(+289.5%) |
| Sep 1990 | - | $1.90M(-74.0%) |
| Jun 1990 | - | $7.30M(+32.7%) |
| Mar 1990 | - | $5.50M(+41.0%) |
| Dec 1989 | $3.90M(-64.2%) | $3.90M(+11.4%) |
| Sep 1989 | - | $3.50M(-67.9%) |
| Dec 1988 | $10.90M(-1.8%) | $10.90M(-1.8%) |
| Dec 1987 | $11.10M(-66.5%) | $11.10M(-66.5%) |
| Dec 1986 | $33.10M(+33.5%) | $33.10M(+33.5%) |
| Dec 1985 | $24.80M(+3000.0%) | $24.80M(+3000.0%) |
| Dec 1984 | $800.00K | $800.00K |
FAQ
- What is Teradyne annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Teradyne?
- What is Teradyne annual cash & cash equivalents year-on-year change?
- What is Teradyne quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Teradyne?
- What is Teradyne quarterly cash & cash equivalents year-on-year change?
What is Teradyne annual cash & cash equivalents?
The current annual cash & cash equivalents of TER is $553.35M
What is the all time high annual cash & cash equivalents for Teradyne?
Teradyne all-time high annual cash & cash equivalents is $1.12B
What is Teradyne annual cash & cash equivalents year-on-year change?
Over the past year, TER annual cash & cash equivalents has changed by -$204.22M (-26.96%)
What is Teradyne quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TER is $475.63M
What is the all time high quarterly cash & cash equivalents for Teradyne?
Teradyne all-time high quarterly cash & cash equivalents is $1.12B
What is Teradyne quarterly cash & cash equivalents year-on-year change?
Over the past year, TER quarterly cash & cash equivalents has changed by -$231.77M (-32.76%)